Cancer Synoptic Reporting Project Group
25 July2022 at 16:30 - 17:30 UTC
Attendees
Scott Campbell Ji-Eun Hwang Suzanne Santamaria Thomas Ruediger Elaine Wooler Jim Case Nicola Ingram rouse dash Laszlo Igali
Meeting Recording (GoogleDrive)
https://drive.google.com/file/d/1iTFcIC9iwR_Ur-4i8lTHvous_8QC-bZT/view?usp=sharing
Discussion items
| Item | Description | Owner | Notes | Action |
|---|---|---|---|---|
| 1 | Histology taxonomy | Members on project team for myeloid histologies - Monica de Baca, Hung Luu, (US hematopathologists); Mark Bishton (UK - haematologist); Donna Morgan Nicola Ingram
|
| |
| 3 | IHC Updates - Presence of substance | Scott Campbell | Modeling for presence of substance. This seems to be set and classified appropriately. Comments? *Model appears to be fine. Reviewed by Suzanne Santamaria . Use of organ of origin of cancer to be used for prognostic stains. Diagnostic stains out of scope of CSRWG. However, model must accommodate diagnostic stains when project progresses. (For example, use of intracellular regions of staining) **See attached IHC design document draft . |
|
| 4 | IHS - Percent staining | Scott Campbell | Modeling will be similar to image pending addition of new denominator concept *Waiting for new concepts to be added to advance these concepts |
|
| 5 | IHC Intensity of stain | Important, but in how many protocols? Can this be a primitive concept for now as in example *Will be primitive until intensity can be defined as a property. |
| |
| 6 | IHC Control Stain function | Scott Campbell | Important, but also a primitive. OK? |
|
| 7 | Anitbody used | Is this sufficient detail? |
| |
| 8 | Additional work items as time allows |
| ||
Meeting Files
| Attachments |
|---|
Previous Meetings
| Content Report Table | ||||||||
|---|---|---|---|---|---|---|---|---|
|